Summary The aim of this study was to investigate the influence of dietary calorie intake at three different fat levels on (a) the growth of established methylnitrosourea (MNU)-induced mammary carcinoma, (b) the reappearance of mammary carcinomas after surgical removal, and (c) the growth of manifest lesions in animals treated with the cytostatic agent hexadecylphosphocholine (HPC). A reduction of calories by 30% significantly inhibited tumour growth of manifest mammary carcinomas in rats, without having a negative influence on body weight gain. After chemotherapeutic treatment no significant dietary influence was observed besides the high antineoplastic efficacy of HPC, but when feeding calorically restricted diets to surgically treated animals the number of reappearing tumours was considerably smaller (P = 0.06) than after feeding the diets ad libitum. The fat content of the diets did not influence the growth of manifest mammary carcinomas. No significant dietary effects were exerted on oestradiol or testosterone levels in untreated tumour bearing animals. An elevation of oestradiol levels was observed when animals were subjected to HPC and fed a high calorie diet. An elevation of testosterone levels was assessed after surgical treatment of the rats, irrespective of fat content and calorie level. Our results suggest that a reduction of calories can inhibit growth of manifest mammary carcinomas and has impeding effects on tumour development after surgical removal. After effective chemotherapeutic treatment the additional influence of dietary changes was of less relevance. Furthermore, our data do not establish any association between growth inhibition of mammary tumours, caused by the mild caloric restriction, and altered oestradiol or testosterone production.
'It is an unfortunate accident of history that ad lib feeding is regarded as the norm for laboratory rats and mice.' 'It is now overdue that restricted feeding be regarded as the norm and as more scientific. ' Roe (1981) The relationship between breast cancer and dietary fat and/or calorie intake has been investigated in many epidemiological and experimental animal studies (Howe et al., 1990; Hulka 1989; McCormick 1989; Welsch 1987) . Both epidemiological and experimental data remain inconsistent concerning the influence of dietary fat or calorie consumption on mammary tumourigenesis. Although several epidemiological studies support the hypothesis of a breast cancer-fat association (Hirayama 1978; Hislop et al., 1986; Hursting et al., 1990; Lubin et al., 1986; Phillips & Snowdon, 1983; Schatzkin et al., 1989; Van't Veer et al., 1990) other studies indicate that dietary factors beside fat play a greater role in the genesis of breast cancer (Graham et al., 1982 , Hirohata et al., 1987 Jones et al., 1987; Mills et al., 1988; Rosen et al., 1988 , Willet et al., 1987 . Data obtained in various experimental animal models are likewise not unanimous concerning the dietary influence of fat intake on chemically induced mammary carcinogenesis. High dietary fat or different types of fatty acids are reported to influence mammary tumourigenesis in animals (Apgar & Shively 1990; Caroll & Khor, 1971; Clinton et al., 1988; Hopkins et al., 1981; Kumaki & Noguchi, 1990; Lasekan et al., 1990; Sundram et al., 1989; Welsch et al., 1990) . In addition, mammary carcinogenesis was described as a function of calorie intake (Beth et al., 1987; Engelmann et al., 1990; Klurfeld et al., 1989; Kritchevsky et al., 1989 , Shao et al., 1990 Biochemical mechanisms responsible for dietary effects in mammary carcinogenesis have only poorly been elucidated (Cave & Hilf, 1987; Welsch, 1987) . Direct effects of fat on tumour development (e.g. changes in the lipid content of the cell membrane and/or synthesis of prostaglandins) and indirect effects on host metabolism such as alterations in the endocrine milieu are under discussion (Cohen, 1981) . Hormones such as insulin (Feldman & Hilf, 1985; Hilf, 1982) , thyroid hormone status (Cave et al., 1977; Vonderhaar, 1982) , glucocorticoids (Aylsworth et al., 1980; Nakamura et al., 1981) , prolactin (Aylsworth et al., 1984; , progesterone (Danguy et al., 1980; Yoshida et al., 1980) , as well as oestrogens (Williams & Dickerson, 1987) All rats received the same diets as the animals of the control group and in addition were treated with 100 mg kg-' HPC intragastrically once a week for 5 weeks (= six subgroups). The duration of feeding these diets was 10 ± 2 weeks. Thereafter the experiment was terminated. The composition of the diets which were obtained from Unilever Research, Rotterdam, The Netherlands, is shown in Table I and the profile of dietary acids is shown in Table II . The effective number of animals in each group is shown in Table III . The fatty acid composition of the diets reflected the fatty acid profile of the normal West German diet (normal diet = ND). All diets were kept frozen at -20°C to minimise lipid peroxidation and were thawed before feeding. All rats received tap water ad libitum.
Evaluation of body weight and tumour growth Body weight, occurrence, number and size of tumours were recorded weekly until the end of the experiment. The tumour size was evaluated by measuring two perpendicular axes with Vernier calipers according to the formula a2 x b/2 (a < b).
The mean tumour volume was calculated from the tumour volumes in individual animals. At the end of the experiment all animals were killed after blood sampling under ether
-CH3 Figure 1 Chemical formula of the cytostatic agent hexadecylphosphocholine (HPC), a compound of the group of ether-lipids. (Koziol & Donna, 1981) . A two way analysis of variance with interactions yielded that there were no interactions present between fat levels and amount of calories. This justified the pooling of the groups for an individual analysis (14) 281 (14) 277(15) 0.0 Group 2 ND45-50 kcal d-' 11 280 (8) 282(16) 297(14) (12) 271(11) 12.5 an = Number ofanimals at termination of study, bND = normal-Diet, percentage of total energy: 45%, 35%, 25%, 'mean (standard deviation), dp = 0.001, ,'p<O.O , significant difference between the body weights of all high caloric groups versus all low caloric groups (Koziol & Donna test) , gtime of dietary change, hweeks after dietary change, itermination of experiment, imortality due to technical failures were excluded from evaluation.
of fat and calorie effects. The recurrence rates of tumours after surgical removal in the respective groups were compared by Fisher's exact test (Sachs, 1983 (Hollander & Wolfe, 1973) .
Results

Body weight
The influence of different fatty diets at two caloric levels on the mean body weight of untreated tumour-bearing animals (control group) is shown in Table III . All groups receiving their diets at a caloric level of 50 kcal per day showed significantly (P = 0.001, multivariate test; test statistics = 13.63) higher body weight gain than rats receiving 35 kcal per day. The restrictively fed groups, however, had no loss of body weight, but kept their mean body weight over the whole experimental period (compare weeks 6 and 11, Table III ). Surgically treated groups of animals (Group 2 -OP) exhibited similar body weight developments (Table III) . Feeding 50 kcal per day produced higher weight gain than feeding 35 kcap per day, but the reduced feeding was not followed by a loss of body weight. After chemotherapeutically treating the rats with HPC (Group 3 -HPC), a slight decrease in body weight was observed during the 5-week period of treatment, both for the high-and the low-calorie groups (Table  III) . While the high calorie groups had an increase in body weight after the end of treatment with the cytostatic agent, the body weight of restrictively fed groups remained stable. Since the initial weight loss did not exceed 10% of the body weight, it had no influence on tumour development. Dietary fat levels did not significantly influence body weight.
Mortality
In untreated tumour-bearing animals as well as in surgically or chemotherapeutically treated animals mortality was not related to the concentration of fat or to the level of calories in the diet (Table III) .
Tumour growth and histology Dietary influences on tumour growth development in untreated tumour-bearing animals (CO) are shown in Table IV . Administration of the diets ND45, ND35 and ND25 at 50 kcal day-' produced greater tumour volumes than feeding the same fat concentrations at 35 kcal day-'. This difference proved to be significant (P = 0.01, multivariate test; test statistics = 8.95) when the tumour volumes of all low-calorie groups were compared with those of all high-calorie groups irrespective of the fat level. After surgical treatment (OP) feeding of calorically restricted diets (ND45, ND35 and ND25) produced smaller tumour volumes than feeding of diets ad libitum (50 kcal d-'). The observed difference between the two caloric levels failed to be significant. Tumour growth development of chemotherapeutically treated animals was effectively inhibited by HPC and remained very close to the detection limit even following the end of treatment; there were no significant differences between the two calorie levels. When the different fat concentrations were compared among all groups, irrespective of the calorie levels neither the control group nor the surgically or chemotherapeutically treated groups showed significant differences in tumour volumes. The histological examination of mammary tumours yielded adenocarcinomas in 94% and adenomas in 6%, irrespective of the dietary groups.
Tumour number
Corresponding to the development of the mean tumour volume, administration of all diets at 50 kcal produced significantly (P = 0.04, multivariate test; test statistics = 6.24) higher tumour numbers than feeding of 35 kcal in untreated tumour-bearing animals. Following surgical or chemotherapeutic treatment, administration of all diets did not cause significant differences in tumour numbers between the two caloric levels (Table IV) , although the difference between the two caloric levels after surgical treatment was very close to the level of significance (P = 0.06, multivariate test; test statistics = 5.61). Comparison of the different fat levels, irrespective of the caloric levels, did not yield any significant differences. total energy: 45%, 35%, 25%, 'mean (standard deviation), dp = 0.01, significant difference between the tumour volumes of all high caloric groups versus the respective low caloric groups, cp = 0.04, fP = 0.06, marginally significant difference between the tumour numbers of all high caloric groups versus the respective low caloric groups, gtime of dietary change, hweeks after dietary change, 'termination of experiment.
Recurrence rates of tumours after surgical removal The influence of dietary fat and calorie intake on the recurrence of tumours after surgical removal is shown in Table V . No significant differences in the recurrence rates of tumours were found between the three fat concentrations or between the two calorie levels except a greater recurrence rate in animals ingesting 50 kcal of the lowest fat diet.
Oestradiol (E2) and testosterone in plasma Plasma levels of oestradiol and testosterone measured after termination of the experiment are shown in Table VI . After chemotherapeutic treatment (Group 3-HPC) a significant increase (P = 0.04, Wilcoxon rank sum test; test statistics = 707.00) in oestradiol levels was found in all high calorie groups in comparison with restrictively fed groups, irrespective of the fat level. Similar trends were observed in the other two groups, but these differences were not statistically significant. No differences in oestradiol levels were found among the three fat concentrations. Testosterone levels in plasma were not significantly influenced by calorie changes. In the control group animals fed 45% fat had significantly (P <0.05, Kruskal Wallis test; test statistics = 8.49) higher testosterone levels than those fed 35% fat. This difference could, however, not be observed in the treated groups (OP and HPC). Additionally, testosterone values of surgically treated animals were generally higher aNumber of animals at termination of study, bnumber (per cent) of recurrences, cNormal-Diet, percentage of energy: 45%, 35%, 25%, dp <0.01, significant difference between the high calorie levels ofgroups ND45 and ND25. 25%, cmean (standard deviation), dP< 0.05, significant difference between the oestradiol levels of all high caloric groups versus the respective low caloric groups, ep < 0.05, significant difference between the testosterone levels of all animals of group 1 versus all animals of group 2, fP < 0.05, significant difference between the testosterone levels of all animals ofgroups fed 45% and 33% fat, irrespective of the calorie intake.
growth both in hormone-dependent (Cohen et al., 1988; Kritchevsky et al., 1986; Pollard et al., 1989) and hormoneindependent tumours (Gross 1988; Pollard et al., 1989) . In this study we investigated the influence of dietary luxury calories at three different fat levels on the growth of manifest MNU-induced mammary carcinomas, on the regrowth of these lesions after surgical removal as well as on the antineoplastic efficacy of the new cytostatic agent HPC in these tumours. Furthermore, we determined plasma oestradiol and testosterone levels at the end of the experiment. Our data show that, even after manifestation of chemically induced mammary carcinomas, a reduction of luxury calories (30% calorie restriction) significantly inhibited tumour growth, irrespective of the fat level. No significant differences in tumour growth were observed when the three fat concentrations were compared. After surgical treatment of the animals, reduction of calories led to remarkable (but not significant) inhibition of tumour growth. Again, the fat content had no influence on the regrowth of tumours. After chemotherapeutic treatment, reduction of neither fat intake nor calorie intake produced additional significant effects on tumour development. These results are in agreement with studies by other authors, who reported on retarded tumour growth and prolonged survival of tumour-bearing rats after restricted food intake. However, there is only scarce information of dietary influences on tumour growth after manifestation of tumours. By feeding semisynthetic diets with a fatty acid composition reflecting the fatty acid profile of the normal West German diet we used diets adapted more to the human situation than it has been described by other authors (Jose & Good, 1973) . Unlike Sandor (1976) who subjected male mice to different schedules of fasting and found a significant tumour retardation, we only tried to avoid 'luxury calories' leading to body fat accumulation and high spontaneous tumor incidence in rodents (Roe, 1981) , and not to subject the animals to periods of starvation since fasting can also stimulate tumour growth (Sauer et al., 1986 ). Siegel et al. (1988 found a significantly enhanced survival of mammary ascites tumour bearing rats after 'mild dietary restrictions' (ad libitum feeding followed by alternate fasting), and suggested on the basis of their data that relatively 'mild dietary restrictions' should be included in clinical trials designed to inhibit cancer growth and enhance the survival of human cancer patients. How 'mild dietary restrictions' in the form of ad libitum feeding followed by alternate fasting can be adapted to the human situation remains open.
Surgical removal of tumours at a size of 1 cm3 followed by reduction of luxury calories led to an almost significant inhibition of new tumour growth but not to a decreased recurrence rate of tumours in our study. Animals ingesting 50 kcal of the lowest fat diet unexpectedly showed a greater recurrence rate than all other groups. This observation can probably be considered a chance association due to the small number of animals in this group. The former finding contrasts to a study by Donegan et al. (1978) who found that the recurrence of breast carcinomas after radical mastectomy was associated with high preoperative body weight: Women with the highest risk of treatment failure weighed in excess of 170 pounds. An explanation for the only mild effect of dietary changes after surgical tumour removal in our study could be that biochemical changes, induced by surgery (Eisele, 1986) , suppressed effects caused by calorie restriction. One piece of evidence supporting this assumption is the generally increased testosterone level in animals of this group.
Chemotherapeutically treated animals subjected to reduced fat and/or calorie intake showed no significant additional retardation of tumour growth in comparison to chemotherapeutically treated animals fed ad libitum. Daly et al. (1980) demonstrated that chemotherapy with methotrexate (MTX) was maximally effective in tumour-bearing rats when they were switched from a protein-free diet to a regular diet, i.e., that nutritional manipulation can increase tumour response to chemotherapy. HPC, which belongs to the group of ether lipids, was as effective as surgical removal of manifest mammary carcinomas . We therefore decided to choose this membrane directed cytostatic agent for treating MNU-induced mammary carcinomas in our study assuming a considerable regrowth of lesions after the end of the therapy. However, HPC exerted a high antineoplastic effect on MNU-induced mammary carcinomas, lasting even after 5 weeks without treatment, which prevented detection of more than minimal numerical differences between high and low calorie fed groups. It is interesting to note, however, that the observed differences in tumour growth and tumour number at the end of dietary treatment were all in favour of the low calorie groups (Table IV Ip & Ip (1981) found significantly lower serum oestradiol levels in DMBA-treated rats fed 0.5% corn oil compared with rats fed 20% corn oil, but no differences between groups fed more realistic fat levels of 5% and 20% corn oil. In an experimental study by Chan et al. (1977) only in the stage of metoestrus-dioestrus total serum oestrogens were significantly higher in MNU-treated rats fed 20% lard than in rats fed 5% lard, the effect of dietary fat on oestrogen concentration, however, did not appear to be related to breast cancer. Unlike the studies mentioned above in which rats were fed diets containing corn oil or lard, we tried to adapt the diets and the feeding regimen to a situation comparable to the human situation. In our study, only animals treated with HPC and fed a high calorie diet had significantly higher oestradiol levels than animals on a low-calorie diet, irrespective of the fat level. The precise mode of the tumour inhibiting action of HPC, is not yet fully understood (Hilgard et al., 1988) . Inhibitory effects of ET-18-OHC3, another ether lipid, on oestradiol uptake into the human breast cancer MCF-7 cells have recently been described (Kosano et al., 1990 
